Perioperative Carcinoid Crisis During Surgery- Who Benefits from Octreotide?

#1607

Introduction: Carcinoid crisis, as an entity is poorly defined, but can be seen in patients with small bowel NET after open bowel surgery or tumour unrelated procedures as cardiovascular instability (CI)

Aim(s): To audit the incidence of CI during procedures and determine the relationship to perioperative octreotide; considering the patient’s underlying disease burden

Materials and methods: Patients were identified from the pathology database having had their primary tumour resected in our institution between Jan2011 and Dec2015. Our prophylactic octreotide protocol is an IV infusion of 50 µg/hr for 24 hrs prior to surgery

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Elgendy K, Johnson S, French J, White S, Charnley R,

Keywords: Octreotide, carcinoid crisis,